Biotechnology Stocks I Performance Guide: Ligand Pharmaceuticals Incorporated (LGND)
LGND has no dividends.
Table and Chart of LGND Performance
See what a $1,000 investment in LGND is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| LGND Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $66.71 |
| End Date | May-17-2024 |
| End Price | $86.06 |
| # Prices | 121 |
| Min Date | Sep-30-2014 |
| Min Price | $46.99 |
| Max Date | Sep-28-2018 |
| Max Price | $274.49 |
| Total Return | 29.01% |
| Annualized Return | 2.56% |
| Current Value of $1,000 Purchase | $1,290 |
| Number Returns | 7,260 |
| Average Return | 11.73% |
| Number Profitable Returns | 3,422 |
| Percent Profitable Returns | 47.13% |
| Number Unprofitable Returns | 3,838 |
| Percent Unprofitable Returns | 52.87% |
| Profitable to Unprofitable Returns Ratio | 0.89 |
| LGND Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,545,956,000 |
| Beta | 0.921 | Price to Sales | 13.02 |
| Earnings per Share | $5.3500 |
| PE Ratio | 16.09 |
| PE to Growth Ratio | 1.527 |
| Price to Book | 1.91 |
| PRICE DATA | |
| 52 Week High | $94.57 |
| 52 Week Low | $49.24 |
| Analyst Target Price | $116.8 |
| 50-Day Moving Average | $75.56 |
| 200-Day Moving Average | $67.79 |
| FINANCIAL DATA | |
| Revenue per Share | $6.77 |
| Revenue | $118,313,000 |
| Profit Margin | 81.4% |
| Return on Equity | 13.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
LGND Compare Returns with S&P 500
LGND Trendline Chart
LGND Moving Average Chart
LGND Stock Return Map - See Patterns of Gains and Losses
LGND Stock Returns/Purchase Dates